TY - JOUR
T1 - Therapeutic Targeting of Inflammatory Pathways with Emphasis on NLRP3 Inflammasomes by Natural Products
T2 - A Novel Approach for the Treatment of Inflammatory Eye Diseases
AU - Soliman, Amro M.
AU - Sim, Ru Hui
AU - Das, Srijit
AU - Mahakkanukrauh, Pasuk
N1 - Funding Information:
The authors acknowledge the technical help received from Dr. Levin Keshu Belani, Department of Orthopedics, UKM Medical Centre, Kuala Lumpur, Malaysia.
Publisher Copyright:
© 2022 Bentham Science Publishers.
PY - 2022/5
Y1 - 2022/5
N2 - There is an increase in the incidence of inflammatory eye diseases worldwide. Several dysregulated inflammatory pathways, including the NOD-like receptor protein 3 (NLRP3) inflammasome, have been reported to contribute significantly to the pathogenesis and progression of ophthalmic diseases. Although the available allopathic/ conventional medicine has demonstrated effectiveness in managing eye diseases, there is an ongoing global demand for alternative therapeutics with minimal adverse drug reactions, easy availability, increase in patient compliance, and better disease outcomes. Therefore, several studies are investigating the utilization of natural products and herbal formulations in impeding inflammatory pathways, including the NLRP3 inflammasome, in order to prevent or manage eye diseases. In the present review, we highlight the recently reported inflammatory pathways with special emphasis on NLRP3 Inflammasomes involved in the development of eye diseases. Furthermore, we present a variety of natural products and phytochemicals that were reported to interfere with these pathways and their underlying mechanisms of action. These natural products represent potential therapeutic applications for the treatment of several inflammatory eye diseases.
AB - There is an increase in the incidence of inflammatory eye diseases worldwide. Several dysregulated inflammatory pathways, including the NOD-like receptor protein 3 (NLRP3) inflammasome, have been reported to contribute significantly to the pathogenesis and progression of ophthalmic diseases. Although the available allopathic/ conventional medicine has demonstrated effectiveness in managing eye diseases, there is an ongoing global demand for alternative therapeutics with minimal adverse drug reactions, easy availability, increase in patient compliance, and better disease outcomes. Therefore, several studies are investigating the utilization of natural products and herbal formulations in impeding inflammatory pathways, including the NLRP3 inflammasome, in order to prevent or manage eye diseases. In the present review, we highlight the recently reported inflammatory pathways with special emphasis on NLRP3 Inflammasomes involved in the development of eye diseases. Furthermore, we present a variety of natural products and phytochemicals that were reported to interfere with these pathways and their underlying mechanisms of action. These natural products represent potential therapeutic applications for the treatment of several inflammatory eye diseases.
KW - BRB
KW - Inflammation
KW - NLRP3 inflammasome
KW - eye diseases
KW - natural products
KW - treatment
UR - http://www.scopus.com/inward/record.url?scp=85130285474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130285474&partnerID=8YFLogxK
U2 - 10.2174/0929867328666210910154330
DO - 10.2174/0929867328666210910154330
M3 - Review article
C2 - 34514977
AN - SCOPUS:85130285474
SN - 0929-8673
VL - 29
SP - 2891
EP - 2912
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 16
ER -